Case Study 3:
Pain Management

Other studies

  1. Sickle cell patient complains about shortness of breath
  2. Patient considering discontinuing Desferol therapy
  3. Pain Manangement
  4. Sß+ Thalassemia patient with acute infarct
  5. Patient with proteinuria
  6. Pregnancy and sickle cell care

Adult Sickle Cell Care Provider: CASE STUDY #3 (Total repondents=5)

Questions: (results presented below question section)

You have been contacted by a care provider in your community because a 32-year-old woman with sickle cell disease (HbSS) has been hospitalized or seen in various ERs 3-4 times/month for complaints of sickle cell pain over the last "several years". She hasn't apparently had any acute complications with her pain (e.g. acute chest syndrome) during this time and has been taking whatever pain medications she can get each time she's seen, usually the short-acting narcotic oxycodone with Tylenol (e.g. Percocet).

In evaluating the patient, you find she reports pain every day in her back and legs which is only partially controlled with 8-10 Percocet tablets a day. A medical evaluation reveals some mild pulmonary hypertension, but no other apparent chronic complication from her sickle cell disease or evidence of other back or intra-abdominal disease as a source of pain.

Given the patient is willing to work with you to manage her pain (as always, more than one answer can be selected if you'd do more than one thing at once):

  1. What would be your first therapeutic approach to her ongoing pain?
    • Drug rehabilitation with gradual withdrawal of all narcotic therapy
    • Use anti-inflammatory therapy (e.g. Ibuprofen, Toradol) instead of narcotics
    • Add anti-inflammatory therapy to narcotic therapy
    • Long-acting narcotics (with short-acting for breakthrough)
      1. Methadone
      2. Sustained-release oxycodone (ie Oxycontin)
      3. Sustained release morphine
      4. Other
    • Short acting narcotics alone
      1. Oxycodone (with or without Tylenol)
      2. Oral codeine (with or without Tylenol)
      3. Hydromorphone (Dilaudid)
      4. Oral morphine sulfate
      5. Other
    • Hydroxyurea therapy
    • Transfusion therapy
      1. Simple transfusion
      2. Exchange transfusion
    • Other
  2. In your experience, how often does this approach work?
    • Almost always
    • Most of the time
    • About half the time
    • Occasionally
    • Almost never, but I always try
  3. If this first line of therapy fails, what will be your second approach?
    • Drug rehabilitation with gradual withdrawal of all narcotic therapy
    • Use anti-inflammatory therapy (e.g. Ibuprofen, Toradol) instead of narcotics
    • Add anti-inflammatory therapy to narcotic therapy
    • Long-acting narcotics (with short-acting for breakthrough)
  4. Methadone
  5. Sustained-release oxycodone (ie Oxycontin)
  6. Sustained release morphine
  7. Other
    • Short acting narcotics alone
  8. Oxycodone (with or without Tylenol)
  9. Oral codeine (with or without Tylenol)
  10. Hydromorphone (Dilaudid)
  11. Oral morphine sulfate
  12. Other
    • Hydroxyurea therapy
    • Transfusion therapy
      1. Simple transfusion
      2. Exchange transfusion
    • Other
  13. How often does this treatment approach work for you?
    • Almost always
    • Most of the time
    • About half the time
    • Occasionally
    • Almost never, but I always try

What Regional/National Meetings do you attend annually?

Would you be interested in attending a meeting of Adult Sickle Cell Providers:

Results of Case #3

Because there were only about 5 responses to this case, I thought I'd forward the specific responses, which were thoughtful and informative. The main theme seems to be:

Everyone acknowledges this is a tough area.

Responses received:

Back to Top